Mucinous carcinoma

ESGO eAcademy, Jonathan Ledermann, 290421

Cancerized teratoma

ESGO eAcademy, Ros Glasspool, 290420

Uterine LMS

ESGO eAcademy, Jae-Weon Kim, 290419

State of the Art 7: ESGO-GCIG Rare Tumours Guidelines

ESGO eAcademy, Isabelle Ray-Coquard, 282788

Radiotherapy in the elderly

ESGO eAcademy, Elzbieta van der Steen-Banasik, 282786

Medical treatment of elderly women with gynaecological cancers: Strategies for a heterogeneous population

ESGO eAcademy, Annamaria Ferrero, 282785

Pre-and postoperative evaluation, morbidity and postoperative outcome of elderly cancer patients

ESGO eAcademy, Dina Kurdiani, 282784

Sex cord tumour

ESGO eAcademy, Isabelle Ray-Coquard, 290425

Low grade serous carcinoma

ESGO eAcademy, Gourley Charlie, 290424

Uterine Carcinosarcomas

ESGO eAcademy, Ronnie Shapira-Frommer, 290418

Ovarian small cell carcinoma

ESGO eAcademy, Clare Scott, 290417

Germ Cell tumour

ESGO eAcademy, Nicoletta Colombo, 290416

Genetic testing: The patient's perspective (patient rep from ENGAGE)

ESGO eAcademy, Birthe Lemley, 282781

Management of Lymph Nodes in Ovarian Cancer

ESGO eAcademy, Philipp Harter, 285950

Genetic counselling for Lynch syndrome in gynaecological cancers

ESGO eAcademy, Pawel Blecharz, 282780

Relevance of lymphadenectomy in cervical cancer in the SLN era

ESGO eAcademy, Fabrice Lecuru, 282775

BRCA mutations: Implications for the patient and family

ESGO eAcademy, Emmanouil Saloustros, 282779

Remaining indications for lymphadenectomy in ovarian cancer

ESGO eAcademy, Nicole Concin, 282774

Parallel session 13: Genetic testing and counselling in gynaecological cancers: Which patients, how, and by whom?

ESGO eAcademy, Susana Banerjee, 282777

Current role of pelvic and aortic lymphadenopathy in endometrial cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 282773

A look at da Vinci robotic-assisted surgery postoperative results

ESGO eAcademy, Celine Lonnerfors, 282770

The place of da Vinci robotic-assisted surgery in an Enhanced Recovery program

ESGO eAcademy, Eric Lambaudie, 282769

Vulvar cancer

ESGO eAcademy, Ate van der Zee, 282767

Endometrial cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 282766

ESGO meta-analysis for triage of HPV-positive cases

ESGO eAcademy, Marc Arbyn, 282760

Up-to-date in cervical cancer screening: ESGO-EFC joint statement

ESGO eAcademy, Jack Cuzick, 282759

Cervical cancer

ESGO eAcademy, David Cibula, 282765

SLN ultrastaging

ESGO eAcademy, Glenn McCluggage, 282764

State of the art in HPV vaccination: ESGO-EFC joint statement

ESGO eAcademy, Elmar Joura, 282758

State of the Art 5: ESGO-EFC new recommendations on prevention

ESGO eAcademy, Murat Gultekin, 282757

Perspectives in novel treatments

ESGO eAcademy, Domenica Lorusso, 282750

Enhanced Recovery Hospital Implementation Process (ERAS): A holistic approach

ESGO eAcademy, Pedro Ramirez, 282756

Pre- and postoperative care: Focussing on nutrition and immunonutrition

ESGO eAcademy, Annamaria Ferrero, 282755

Is there a role for radiotherapy in high-risk early-stage disease?

ESGO eAcademy, Carien Creutzberg, 282749

Perioperative anaesthetic management

ESGO eAcademy, Carolyn Weiniger, 282754

Is there a role for chemotherapy in high-risk early-stage disease?

ESGO eAcademy, Faculty / Presenters, 282748

The role of the Intensive Care Unit (ICU) in postoperative management

ESGO eAcademy, Nikolaos Thomakos, 282753

Endometrial cancer: A single disease?

ESGO eAcademy, Tjalling Bosse, 282747

Presidential lecture

ESGO eAcademy, Denis Querleu, 282744

Surgical performance

ESGO eAcademy, Karl Tamussino, 282742

QI related to patients´ management

ESGO eAcademy, Francesco Raspagliesi, 282741

How to develop and how to use QI

ESGO eAcademy, David Cibula, 282740

Lessons learned: EWOC-1/EORTC55944/ PORTEC-3*

ESGO eAcademy, Nicoletta Colombo, 282737

First line ovarian cancer trials: VELIA/Forward1

ESGO eAcademy, Faculty / Presenters, 282736

PARP combination studies: PRIMA/PAOLO-1/ANVANOVA2

ESGO eAcademy, Jonathan Ledermann, 282735

CON: open radical hysterectomy should be the new standard of care

ESGO eAcademy, Pedro Ramirez, 282728

PRO: Minimally invasive radical hysterectomy should remain the standard approach

ESGO eAcademy, Henrik Falconer, 282727

Discussion

ESGO eAcademy, Nadeem R. Abu-Rustum, 286497

Prognostic relevance of the molecular classification in high-risk endometrial cancer: analysis of the PORTEC-3 trial

ESGO eAcademy, Alicia Leon-Castillo, 286496

Development and validation of an endometrial carcinoma preoperative Bayesian network using molecular and clinical biomarkers (ENDORISK): an ENITEC collaboration study

ESGO eAcademy, Casper Reijnen, 286495

Lympho-vascular space invasion is strongly associated with lymph node metastases and decreased survival in endometrioid endometrial cancer: a Swedish Gynecologic Cancer Group (SweGCG) study

ESGO eAcademy, Karin Stalberg, 286494

Conservative treatment of atypical endometrial hyperplasia and early endometrial cancer: a prospective single institution study of 418 patients

ESGO eAcademy, Olga Novikova, 286493

Update on chemotherapy and targeted therapy of high-grade serous carcinomas

ESGO eAcademy, Nicoletta Colombo, 282719

Quality assurance in ovarian cancer surgery

ESGO eAcademy, Andreas du Bois, 282724

Surgical management of early, advanced, and recurrent adnexal carcinomas

ESGO eAcademy, Denis Querleu, 282718

Quality assurance in endometrial cancer surgery

ESGO eAcademy, Jan Persson, 282723

Pathology and pathologic markers of extra-uterine high-grade serous carcinoma

ESGO eAcademy, Glenn McCluggage, 282717

Quality assurance in cervical cancer surgery

ESGO eAcademy, Andreas Obermair, 282722

The development of checkpoint inhibitor combinations: Which future?

ESGO eAcademy, Eric Lauraine, 282714

Laparoscopic scores to predict operability: Are they sufficient to stratify patients safely into surgical pathways?

ESGO eAcademy, Giovanni Scambia, 282708

How to detect and manage immunotherapy toxicity

ESGO eAcademy, Domenica Lorusso, 282713

How to incorporate tumour biology into tailoring surgical efforts

ESGO eAcademy, Christina Fotopoulou, 282707

Checkpoint inhibitors in gynaecological cancers: What are the data?

ESGO eAcademy, Christian Marth, 282712

Surgery at relapse: How to select optimal surgical candidates?

ESGO eAcademy, Andreas du Bois, 282706

Immunotherapy in gynae-oncology: Why and how?

ESGO eAcademy, Lana Kandalaft, 282711

Fragility scores stratifying patients to radical upfront versus interval debulking surgery: Results of the TRUST- FRAGILE study

ESGO eAcademy, Felix Hilpert, 282705

Discussion

ESGO eAcademy, Christina Fotopoulou, 286492

SENTIX - Sentinel lymph node in patients with cervical cancer: time to voiding recovery after surgery (CEEGOG-CX01; ENGOT-CX2; NCT02494063)

ESGO eAcademy, Ignacio Zapardiel, 286491

Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer

ESGO eAcademy, Agnieszka Rychlik, 286490

Surgical algorithm for sentinel lymph nodes detection in early-stage cervical cancer

ESGO eAcademy, Fabrice Lecuru, 286489

SUCCOR study. An international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009,< 4 cm) cervical cancer operated in 2013-2014

ESGO eAcademy, Luis Chiva, 286488

Role of NACT in cervical cancer

ESGO eAcademy, Stefano Greggi, 287797

Abnormal Colposcopy Interactive Case Series

ESGO eAcademy, Mihaela Grigore, 287798

Sexuality in cancer survivors

ESGO eAcademy, Annette Hasenburg, 287799

Immunotherapy as a future in the treatment of malignant tumours

ESGO eAcademy, Jan Kotarski, 287800

Why brachytherapy is a crucial component of the management of cervical cancer

ESGO eAcademy, Cyrus Chargari, 287801

Definitive (chemo) radiotherapy of cervical cancer with nodal boost

ESGO eAcademy, Jacob Lindegaard, 287802

The IOTA system in the diagnosis of suspicious ovarian masses

ESGO eAcademy, Dirk Timmerman, 287803

Challenges Facing Colposcopy

ESGO eAcademy, Charles Redman, 287805

Nutrition, endogenous hormone metabolism, and cancers of the breast, endometrium, and ovary

ESGO eAcademy, Rudolf Kaaks, 287806

Pharmacologic maneuvers to control bleeding in surgery

ESGO eAcademy, Jeremy Campbell, 287807

Pro HIPEC

ESGO eAcademy, Willemien Van Driel, 287808

FIGO classification - Ongoing Challenges'

ESGO eAcademy, Sean Kehoe, 287809

Techniques of Radical Hysterectomy. On the shoulders of giants. Great ppt on the history of Radical hysterectomy.

ESGO eAcademy, Luis Chiva, 287810

Succor study

ESGO eAcademy, Luis Chiva, 287811

Anti HIPEC

ESGO eAcademy, Ignace Vergote, 287812

Molecular tumour board in uterine sarcomas

ESGO eAcademy, Sigurd Lax, 287813

Cervical cancer prevention - a changing scene

ESGO eAcademy, Maria Kyrgiou, 287814

What you considered a leiomyoma appeared to be a sarcoma: What to do and how to prevent it?

ESGO eAcademy, Mehmet Mutlu Meydanli, 287815

Challenge to prevent uterine sarcoma morcellation

ESGO eAcademy, Frederic Amant, 287816

New Generation Colposcopies

ESGO eAcademy, Murat Gultekin, 287817

The vaginal microbiome, HPV infection, and progression of cervical disease

ESGO eAcademy, Murat Gultekin, 287818

Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery

ESGO eAcademy, Marlene Kranawetter, 287804

Laparoscopic radical trachelectomy: step by step

ESGO eAcademy, Ali Kucukmetin, 285194

Current indications for LND in epithelial ovarian cancer in the post-LION era

ESGO eAcademy, Christina Fotopoulou, 285141

Urinary diversion procedures in gynecologic oncologic surgery.
Part III: Laparotomic Miami Pouch in 10 steps

ESGO eAcademy, Carlos Martinez Gomez, 283327

Nerve sparing surgery

ESGO eAcademy, Berta Diaz Feijo, 280227

Urinary diversion procedures in gynecologic oncologic surgery.
Part II: Ileal orthotopic neobladder in 10 steps

ESGO eAcademy, Carlos Martinez Gomez, 279754

References & Assessment | Session 2 - Endometrial cancer

ESGO eAcademy, Course Faculty, 278029

References & Assessment | Session 1 - Diagnostic pathways and patients

ESGO eAcademy, Course Faculty, 278028